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Original Article
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Marjolein A. Heuvelmans1,5, Shiyuan Liu6, Matthijs Oudkerk7, Geertruida H. de Bock1
1Department of Epidemiology, 2Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, The 
Netherlands; 3Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, 
Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China; 4Department of Pulmonary Diseases, University of Groningen, 
University Medical Centre Groningen, Groningen, The Netherlands; 5Department of Pulmonology, Medisch Spectrum Twente, Enschede, The 
Netherlands; 6Department of Radiology, Shanghai Changzheng Hospital, The Second Military Medical University Shanghai, Shanghai 200003, 
China; 7University of Groningen, Groningen, The Netherlands
Contributions: (I) Conception and design: Y Du, G Sidorenkov, HJM Groen, R Vliegenthart, MA Heuvelmans, S Liu, M Oudkerk, GH de Bock; (II) 
Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: Y Du, X Cui, G Sidorenkov, 
S Liu, GH de Bock; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All 
authors.
Correspondence to: Geertruida H. de Bock. Department of Epidemiology, University of Groningen, University Medical Center Groningen, 
Groningen, PO Box 30.001, FA 40, 9700 RB Groningen, The Netherlands. Email: g.h.de.bock@umcg.nl. 
Background: Quantifying the occurrence of lung cancer due to passive smoking is a necessary step when 
forming public health policy. In this study, we estimated the proportion of lung cancer cases attributable to 
passive smoking among never smokers in China.
Methods: Six databases were searched up to July 2019 for original observational studies reporting relative 
risks (RRs) or odds ratios (ORs) for the occurrence of lung cancer associated with passive smoking in 
Chinese never smokers. The population attributable fraction (PAF) was then calculated using the combined 
proportion of lung cancer cases exposed to passive smoking and the pooled ORs from meta-analysis. Data 
are reported with their 95% confidence intervals.
Results: We identified 31 case-control studies of never smokers and no cohort studies. These comprised 
9,614 lung cancer cases and 13,093 controls. The overall percentages of lung cancers attributable to passive 
smoking among never smokers were 15.5% (9.0–21.4%) for 9 population-based studies and 22.7% (16.6–
28.3%) for 22 hospital-based studies. The PAFs for women were 17.9% (11.4–24.0%) for the population-
based studies and 20.9% (14.7–26.7%) for the hospital-based studies. The PAF for men was only calculable 
for hospital-based studies, which was 29.0% (95% CI: 8.0–45.2%). Among women, the percentage of 
lung cancer cases attributable to household exposure (19.5%) was much higher than that due to workplace 
exposure (7.2%).
Conclusions: We conclude that approximately 16% of lung cancer cases among never smokers in China 
are potentially attributable to passive smoking. This is slightly higher among women (around 18%), with 
most cases occurring due to household exposure.
Keywords: Population attributable fraction (PAF); environmental tobacco smoke; passive smoking; secondhand 
smoke; lung cancer
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Introduction
Environmental tobacco smoke is a common source of 
indoor air pollution worldwide (1,2), and its inhalation is 
known as passive smoking. Importantly, the International 
Agency for Research on Cancer has stated that passive 
smoking exposes people to the same carcinogens as active 
smoking, which is the leading cause of lung cancer (3). 
Consequently, passive smoking is considered an important 
cause of lung cancer in never smokers (3,4), increasing 
their risk of the disease (5). The biological plausibility for 
this association is that carcinogens and toxic substances 
seem to remain present in side-stream smoke and exhaled 
mainstream smoke (6-8).
Exposure to passive smoking continues to be a major 
public health concern, resulting in a large economic burden 
worldwide, including in China (1,9). Worldwide, it is 
estimated that 40% of children, 33% of males, and 35% of 
females identified as never smokers are exposed to passive 
smoking. The situation in China is complicated by having 
more tobacco consumers than any other country, with 316 
million current smokers exposing more than 50% of never 
smokers to passive smoking in the home and workplace 
in 2015 (10). Depending on the study, estimates indicate 
that exposure to passive smoke in China varies from 34.1% 
to 72.4% (11-15). This wide range can be explained by 
variations in age and sex, as well as the region, source, and 
definition of exposure. Nevertheless, the large number of 
smokers necessitates that we quantify the effect of smoking 
on never smokers in the Chinese population to guide public 
health decisions.
In this systematic review, we aimed to estimate the 
proportion of lung cancers in never smokers that could 
be deemed attributable to passive smoking. To do so, we 
estimated the expected proportional reduction in lung 
cancer occurrence as if there had been no exposure to 
passive smoking, the so-called population attributable 
fraction (PAF) (16), assuming a causal relationship between 
passive smoking and lung cancer.
Methods
Data sources and search strategy
We conducted a comprehensive search of six databases for 
publications in English or Chinese in accordance with the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis statement (17). Articles published in English 
were identified through the PubMed and Web of Science 
databases. Those published in Chinese were found through 
the China National Knowledge Infrastructure, Database 
of Chinese Scientific & Technical Periodicals, Wan 
Fang database, and the China Biology Medical literature 
database.
All databases were searched from inception to July 2019 
to identify original observational studies that reported 
relative risks (RRs) or odds ratios (ORs) of the association 
between passive smoking and lung cancer in Chinese never 
smokers. The following search terms were used: “tobacco 
smoke,” “secondhand smoking,” “passive smoking,” “lung 
cancer,” “China,” and “Chinese.” A detailed summary of the 
search strategy used in each database is described in Table S1. 
Additionally, we manually searched the reference lists of 
retrieved articles to identify relevant studies that were not 
revealed by the database search.
Eligibility criteria and study selection
Studies were included in the systematic review if they met 
the following criteria: participants were never smokers from 
China (including Taiwan), passive smoking was assessed 
at an individual level, risk estimates were reported for the 
occurrence of primary lung cancer, and a case-control 
or cohort design was used. Studies were excluded for the 
following reasons: if they focused on a specific occupational 
population (e.g., miners, catering workers, textile workers, 
oil field workers, or those exposed to asbestos or nuclear 
fuel); if they included residents of Xuanwei County of 
Yunnan Province [residents in this area have exceptionally 
high exposure to residential smoky coal emissions, which is 
associated with a 36-fold increase in lung cancer mortality 
in men and a 99-fold increase in women compared with 
smokeless coal (18)]; if the outcome of interest was the 
specific mortality instead of the occurrence of lung cancer; 
and if the proportion of primary lung cancer cases exposed 
to passive smoking was unavailable to calculate PAF. In the 
event of multiple publications from a single study, the most 
recent publication was selected.
Three reviewers independently screened the identified 
studies for inclusion. YD screened all studies, GS screened 
those published in English, and XC screened those 
published in Chinese. After a calibration session, any 
disagreement was mediated by a fourth reviewer (GHdB 
for the studies published in English and SL for the studies 
published in Chinese).
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Data extraction and quality assessment
One author (Y Du) extracted data using a standardized 
extraction sheet (Figure S1)  and two co-authors (G 
Sidorenkov, X Cui) reviewed the data. For each selected 
publication, three reviewers (Y Du, G Sidorenkov, X Cui) 
independently assessed the quality of included studies using 
the Newcastle-Ottawa Scale (NOS) (19). The NOS is a 
methodological assessment tool recommended for use with 
cohort and case-control studies that uses a star-based scale 
ranging from 0 to 9 stars (20). Quality is assessed on three 
domains in the NOS: (I) study group selection; (II) group 
comparability; and (III) exposure/outcome reliability. The 
comparability assessment needed to be further specified 
based on the topic of the analysis, which was done in a 
consensus meeting among the authors before assessing the 
studies. It was agreed that one star would be given when 
the comparison between cases and controls was adjusted 
for age and sex. Another star was given when there was 
adjustment for at least one of the following confounders: 
radon, asbestos, family history of lung cancer and cooking 
smoke. Any disagreements were settled by consensus or 
were adjudicated by a third reviewer (GHdB/SL). Studies 
assessed as zero points for the comparability domain were 
excluded from the meta-analysis.
Data analyses and syntheses
The first step involved a meta-analysis of the OR and 
corresponding 95% confidence intervals (CIs), using 
a random effects model. We performed I2 tests and 
considered data to have heterogeneity when the I2 value was 
>50%. For studies that reported both crude and adjusted 
OR estimates, the adjusted risk estimate was selected for 
the meta-analysis. For studies that reported stratified ORs, 
the overall OR was calculated by combing the stratified 
ORs and using them in the subgroup PAF calculations, as 
applicable. For studies that did not report OR directly, but 
where the necessary data were available, we performed the 
OR calculation ourselves. The derivation of the ORs used 
in the study, together with their matched/adjusted factors in 
each included study, are presented in Table S2. To evaluate 
the robustness of the pooled ORs, we performed sensitivity 
analyses in which each study was sequentially removed and 
the OR was recalculated. Publication bias was tested using 
Begg’s test and a funnel plot.
The next step involved calculating the point estimate of 
PAF based on the pooled proportion of exposed cases and 







where pc is the percentage of cases exposed in the combined 
population.
RR was replaced with the OR (as an approximation of 
the RR) for case-control studies (16). The 95% CI of the 
PAF was then estimated according to a formula described 
elsewhere, in which the variance of both the OR and the 
exposed cases were considered (21):
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The upper limit (UL) and lower limit (LL) of PAF were calculated as 1-exp{LL[ln(1-PAF)]} and 1-exp{UL[ln(1-PAF)], 
respectively. 
The meta-analysis was performed using Stata/SE software, version 15.0 (StataCorp., college Station, TX; package 
“pr0012”), and the PAF estimations were performed using Microsoft Excel 2010 (Microsoft Corporation, Washington).
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Records identified through database 
searching (n=2,359)
Publications in English: n=908
PubMed: 493; Web of science: 415
Publications in Chinese: n=1,451
CNKI: 234; WF: 442; VIP: 523; CBM: 252
Additional records identified 
through references 
(n=3)
Records after duplicates 
removed 
(n=1,585)
Records for title and abstract 
screened 
(n=1,585)
Full-text articles assessed for 
eligibility (n=296)
Publications in English: 
n=156
Publications in Chinese: 
n=140





Full-text articles excluded, with reasons (n=265)
- Not case-control or cohort designed: 46
- Population is not non-smokers: 49
- Population is occupational workers: 1
- Outcome is mortality of lung cancer: 3
- Passive smoking is not studied: 99
- OR/RR with 95% CI is unavailable: 23
- No. of cases exposed is unavailable: 10
- Full-text is not available: 24
- From the same research: 8















Figure 1 Selection of studies for inclusion in the systematic review. CBM, and the China Biology Medical literature database; CNKI, China 
National Knowledge Infrastructure; VIP, Database of Chinese Scientific & Technical Periodicals; WF, Wan Fang database.
Results
Eligible studies and their characteristics
We identified 2,359 articles from the six databases we 
searched and retrieved 296 papers for full-text review; of 
these, 31 case-control studies [22 published in English (22-43) 
and 9 published in Chinese (44-52)] were eligible for 
inclusion (Figure 1). No cohort studies fulfilled the inclusion 
criteria. The details of all included studies are summarized 
in Table 1.
The average methodological quality score was 6.0±0.9, 
ranging from 5 to 8 (≥7 for 9 studies). Details of the quality 
assessment are presented in Table S3. Concerning exposure 
ascertainment, 29 studies had no blinding to the case/
control status during interviews. Notably, the definitions of 
never smoker and passive smoking varied across the studies, 
as presented in Table S4. 
Among the eligible studies, 9,614 cases of lung cancer 
and 13,093 controls were included, with exposure to passive 
smoking in 5,923 (61.6%) and 7,089 (54.1%), respectively. 
Overall, 11 studies included both men and women, 19 
studies included only women, and 1 study included only 
men. The age of the population of interest in the included 
studies varied and was presented either as mean and 
standard deviation or percentage, as shown in Table 1. 
Most studies (n=22) were conducted in mainland China. 
The control groups were recruited from a hospital in 22 
studies, but they were population-based in the remaining 
9 studies. All but 5 studies, which were limited to lung 
adenocarcinoma, included all types of lung cancer. Of 
the 20 studies that provided data on the source of passive 
smoking, 18 considered both home and work exposure, 2 
considered home exposure only, and 1 considered work 
exposure only.
208 Du et al. Lung cancer occurrence attributable to passive smoking
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The PAF for lung cancer due to passive smoking
The pooled OR for lung cancer risk attributed to passive 
smoking in never smokers was 1.50 (95% CI: 1.35–1.67) 
(Figure 2), which was robust in the sensitivity analysis 
(Figure S2). However, heterogeneity was observed across the 
studies (I2=60.4%, P<0.001) and there was some evidence of 
publication bias according to Begg’s test (P=0.041) and an 
asymmetric funnel plot (Figure S3). The percentage of cases 
exposed to passive smoking was 61.6% (5,923/9,614), and 
the overall PAF for lung cancer due to passive smoking was 
20.5% (95% CI: 15.9–24.9%).
The PAF for lung cancer due to passive smoking in 
population- and hospital-based studies
T h e  p o o l e d  O R  f o r  p a s s i v e  s m o k i n g  a n d  l u n g 
cancer  r i sk  in  never  smokers  was  1 .36 (95% CI: 
1 . 1 9 – 1 . 5 6 )  f o r  t h e  9  p o p u l a t i o n - b a s e d  s t u d i e s 
(Figure 3). Moreover, no heterogeneity was observed 
across the studies (I2=0%, P=0.537), and there was 
no  publ ica t ion  b ias ,  a s  ind icated  by  Begg’s  tes t 
(P=0.754) and a symmetrical funnel plot (Figure S4). 
In population-based studies, the PAF for lung cancer due to 
passive smoking was 15.5% (95% CI: 9.0–21.4%).
Figure 2 Forest plot of the random effects meta-analysis for the association between passive smoking and lung cancer among never smokers 
in China. CI, confidence interval; OR, odds ratio.
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The pooled OR for passive smoking and lung cancer 
risk in never smokers was 1.57 (95% CI: 1.36–1.81) for the 
22 hospital-based studies (Figure 3). However, substantial 
heterogeneity was observed (I2=69.2%, P<0.001), and there 
was some evidence of publication bias, as indicated by Begg’s 
test (P=0.048) and an asymmetrical funnel plot (Figure S5). 
In the hospital-based studies, the PAF for lung cancer due to 
passive smoking was 22.7% (95% CI: 16.6–28.3%) (Table 2).
The PAF for lung cancer due to passive smoking in men 
and women
For the population-based studies, the pooled OR for passive 
smoking and lung cancer risk in female never smokers 
was 1.45 (95% CI: 1.25–1.68), with no heterogeneity 
(I2=0.0%, P=0.593) (Figure S6). The PAF for lung cancer 
due to passive smoking in this group was 17.9% (95% CI: 
11.4–24.0%). The non-significant OR was yielded from 
the small number of population-based studies reporting the 
association between passive smoking and lung cancer risk 
in male never smokers meant that the PAF could not be 
estimated.
For the hospital-based studies, substantial heterogeneity 
was observed across studies (studies in females: I2=65.0%, 
P<0.001; studies in males: I2=77.2%, P=0.002) (Figure S7). 
The PAF for lung cancer due to passive smoking was 20.9% 
Figure 3 Forest plot of the random effects meta-analysis for the association between passive smoking and lung cancer among never smokers 
in China by study setting. CI, confidence interval; OR, odds ratio.
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(95% CI: 14.7–26.7%) in females and 29.0% (95% CI: 
8.0–45.2%) in males (Table 2).
The PAF for lung cancer due to passive smoking in women, 
based on exposure source
The pooled OR for passive smoking at home and lung 
cancer risk among female never smokers was 1.42 (95% CI: 
1.21–1.67), with no significant heterogeneity (I2=40.8%, 
P=0.107) (Figure S8). The PAF for lung cancer due to 
passive smoking at home was 19.5% (95% CI: 11.4–26.9%). 
The pooled OR for passive smoking in the workplace and 
lung cancer risk among female never smokers was 1.58 (95% 
CI: 1.33–1.88), with no heterogeneity (I2=0.0%, P=0.962). 
The PAF for lung cancer due to passive smoking in the 
workplace was 7.2% (95% CI: 4.6–9.7%) (Table 3).
The PAF for lung cancer due to passive smoking by 
histological type
T h e  p o o l e d  O R  f o r  p a s s i v e  s m o k i n g  a n d  l u n g 
adenocarcinoma risk from the population-based studies was 
1.58 (95% CI: 1.11–2.25), with no significant heterogeneity 
across studies (I2=40.4%, P=0.169). The PAF for lung 
adenocarcinoma due to passive smoking was 28.2% (95% CI: 
7.8–44.0%). PAF could not be estimated for the association 
between passive smoking and squamous cell carcinoma in 
never smokers because of the non-significant OR yielded 
from limited number of studies (Table 4, Figure S9).
Discussion
Main findings
We conducted a systematic review and meta-analysis 
based on evidence from nearly 23,000 participants in 31 
studies. Our aim was to estimate the proportion of lung 
cancer cases that could be prevented by eliminating passive 
smoking in Chinese never smokers. Overall, using the PAF, 
we showed that approximately one-fifth of lung cancer 
cases were attributable to passive smoking, with a lower 
proportion from population-based studies (15.5%) than 
from hospital-based studies (22.7%). Given that population-
based studies allow for more precise comparisons between 
cases and controls in a target population (53), data from 
these may have been more reliable (21). Furthermore, we 
demonstrated good homogeneity and no publication bias 
across the included population-based studies, indicating that 
the estimate from these data was unbiased. We conclude 
that the PAF estimate of 15.5% from population-based case-
control studies was reliable. Regarding to the histological 













95% CI I2 P PAF 95% CI
Population-based 9 6.4±1.0 2,172 1,268 58.4 1.36 1.19–1.56 0.0% 0.537 15.5% 9.0–21.4%
Women 8 6.4±1.1 1983 1,146 57.8 1.45 1.25–1.68 0.0% 0.593 17.9% 11.4–24.0%
Men 3 6.7±0.6 189 122 64.6 1.00 0.68–1.48 0.0% 0.755 – –
Hospital-based 22 5.8±0.8 7,442 4,655 62.6 1.57 1.36–1.81 69.2% <0.001 22.7% 16.6–28.3%
Women 19 5.8±0.8 5,946 3,731 62.8 1.50 1.31–1.73 65.0% <0.001 20.9% 14.7–26.7%
Men 5 6.4±0.5 555 350 63.1 1.85 1.10–3.10 77.2% 0.002 29.0% 8.0–45.2%
CI, confidence interval; I2, study heterogeneity; NOS, Newcastle-Ottawa Scale; OR, odds ratio; PAF, population attributable fraction.












95% CI I2 P PAF 95% CI
Household 8 6.5±0.9 2,606 1,720 66.0 1.42 1.21–1.67 40.8% 0.107 19.5% 11.4–26.9%
Workplace 6 6.8±0.8 2,379 465 19.6 1.58 1.33–1.88 0.0% 0.962 7.2% 4.6–9.7%
CI, confidence interval; I2, study heterogeneity; NOS, Newcastle-Ottawa Scale; OR, odds ratio; PAF, population attributable fraction.
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type of lung cancer, compared to the studies including all 
histological types, the proportion of lung adenocarcinoma 
caused by passive smoking in never smokers was higher 
(28.2% vs. 17.7%) based on the population-based studies.
The proportion of lung cancer cases that could be 
prevented among women by stopping passive smoking was 
18% in this study, which was lower than the 24% reported 
in a previous estimate from 2008 (54). However, the RR of 
passive smoking for lung cancer was comparable with that 
in the previous publication, implying that there has been an 
overall decrease in the prevalence of passive smoking. This 
could be because China officially signed the Framework 
Convention on Tobacco Control in 2003 (55), which has 
resulted in several smoke-free policies being implemented 
(56-58). Additional positive effects on lung cancer 
occurrence can be expected from these measures because 
smoking rates decline slowly. The risk of lung cancer in 
exposed individuals may therefore decline further over time 
as exposure to passive smoking reduces.
The overall proportion of lung cancers attributable 
to passive smoking in Chinese never smokers (16%) 
was similar to that estimated for the United Kingdom 
(14–15%) in 2010 (59). However, it was much higher 
than that reported for the United States in 2014, where 
passive smoking contributed to only 2.7% of lung cancers 
(3.1% for men, 2.3% for women) in both never and ever 
smokers (60). The prevalence of smoking in the United 
States has decreased over several years (61), and it has 
been reported that the prevalence of passive smoking in 
nonsmokers was only 25.2% in 2014 (62). In the present 
study, the PAF for female never smokers for China (18%) 
was close to that estimated for Korea in 2009 (20.7%) (63) 
and Japan in 2005 (18.9%) (64). By contrast, in France, 
6.7% of female lung cancers were attributable to domestic 
passive smoking, a rate that is much lower than reported 
for female never smokers in China (65). This could be due 
to the comparatively higher prevalence of passive smoking 
in China. Indeed, according to surveys in 2015, exposure to 
passive smoking in the home among female never smokers 
was 51.4% in China (10), whereas it was reported to range 
from 2.9% to 42.8% (increasing with age) in France (65).
The proportion of lung cancers attributable to passive 
smoking in the home (19.5%) was much higher than that 
in the workplace (7.2%) among women. The main reason 
for this appeared to be that more women were exposed to 
passive smoking in the home (66.0%) than in the workplace 
(19.6%). According to a survey of adults aged ≥40 years in 
China, 37.7% of never smokers exposed to passive smoking 
reported that they were usually exposed at home, whereas 
only 7.1% reported that they were usually exposed in the 
workplace (14). The home is therefore the predominant site 
of exposure to passive smoking, especially for women and 
children (12). One study indicated that this may reflect a 
displacement effect due to smoke-free legislation, with the 
net effect being that people smoke more frequently at home 
to avoid the restrictions in place at public places (66). As a 
priority, we therefore recommend that public health policy 
in China aim to reduce passive smoking in the home.
Limitations
Estimating the PAF in a systematic review and meta-analysis 
is an alternative approach when data on exposure rates are 
not available from national surveys. However, there are 













95% CI I2 (%) P PAF (%) 95%CI
All histological types 26 6.1±0.9 7,721 4,739 61.38 1.55 1.38–1.75 58.3 <0.001 21.8 16.8–26.5%
Population-based studies 8 6.4 ±1.1 1,674 1,196 71.45 1.33 1.15–1.53 0.0 0.539 17.7 9.2–25.4%
Hospital-based studies 18 5.9±0.8 6,047 3,543 58.59 1.67 1.43–1.96 66.5 <0.001 23.5 17.6–29.0%
Adenocarcinoma 10 6.2±1.0 2,509 1,651 65.80 1.48 1.18–1.86 66.0 0.002 21.3 10.3–31.0%
Population-based studies 4 7.0±0.8 559 429 76.74 1.58 1.11–2.25 40.4 0.169 28.2 7.8–44.0%
Hospital-based studies 6 5.7±0.8 1,950 1,222 62.67 1.44 1.07–1.95 75.5 0.001 19.1 4.7–31.4%
Squamous cell carcinoma 3 6.7±0.6 101 57 56.44 1.36 0.80–2.32 0.0 0.400 – –
CI, confidence interval; I2, study heterogeneity; NOS, Newcastle-Ottawa Scale; OR, odds ratio; PAF, Population attributable fraction.
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some limitations in the study. First, we used the OR from 
case-control studies as an approximation of the RR because 
there were no eligible cohort studies. Although this is not 
ideal, the OR from a case-control study is considered a 
valid substitute for the RR from a cohort study when a 
disease is uncommon (16). Second, we could not control 
for the effects of cooking fumes when estimating the PAF 
of lung cancer due to passive smoking in the home, which 
might have resulted in an overestimation of the PAF. Third, 
most of the studies had no blinding to the case/control 
status during interview, indicating a possible high risk of 
information or misclassification bias. Fourth, the PAF for 
male never smokers could not be estimated because there 
were insufficient population-based studies.
Conclusions
The results of this review and meta-analysis indicate that 
passive smoking contributes to about 16% of lung cancers 
in Chinese never smokers, but that this increases to 18% in 
females. Further measures are needed to control against the 
harmful effects of passive smoking, especially in Chinese 
women, and we recommend that public health efforts 
should prioritize reducing levels of passive smoking in the 
home. It appears that the biggest gains can be achieved 
here, not only by preventing lung cancer but also by 
preventing other diseases associated with passive smoking.
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Supplementary
Table S1 Database search strategy
Database Search strategy
PubMed ((“Lung Neoplasms” [Mesh] OR ((lung[tiab] OR lungs[tiab] OR pulmonary[tiab]) AND (cancer*[tiab] OR 
neoplasm* OR tumor*[tiab] OR tumour*[tiab] OR carcinoma*[tiab] OR adenocarcinoma*[tiab]))) AND 
(“Tobacco Smoke Pollution” [Mesh] OR (smok*[tiab] AND (second-hand[tiab] OR secondhand[tiab] 
OR passive[tiab] OR involuntary[tiab] OR environmental[tiab] OR expos*[tiab]))) AND (“China”[Mesh] 
OR “Taiwan” [Mesh] OR China [tiab] OR Chinese [tiab] OR Taiwan* [tiab]) ) NOT (“Animals”[Mesh] NOT 
“Humans”[Mesh])
Web of Science (core 
collection)
(TS=((lung OR lungs OR pulmonary) AND (neoplasm* OR cancer* OR tumo* OR carcinoma* OR 
adenocarcinoma*))) AND (TS=(Smok* AND (secondhand OR second-hand OR passive OR involuntary OR 
environmental))) AND (TS=(China OR Chinese OR Taiwan))
China National Knowledge 
Infrastructure (in Chinese)
(SU= ‘lung cancer’ OR SU= ‘lung adenocarcinoma’ OR SU= ‘squamous cell lung carcinoma’ OR 
SU= ‘malignant tumor of lung’) AND (SU= ‘secondhand smoke’ OR SU= ‘passive smoking’ OR SU= 
‘environmental tobacco smoke’ OR SU= ‘indirect smoking’) 
Wan Fang database (in 
Chinese)
(“lung cancer”+”lung adenocarcinoma”+”squamous cell lung carcinoma”+”malignant tumor of lung”) * 
(“secondhand smoke”+”passive smoking”+”environmental tobacco smoke”+”indirect smoking”)
Database of Chinese 
Scientific & Technical 
Periodicals (in Chinese)
(M=lung cancer OR M=lung adenocarcinoma OR M=squamous cell lung carcinoma OR M=malignant 
tumor of lung OR R= lung cancer OR R=lung adenocarcinoma OR R=squamous cell lung carcinoma OR 
R=malignant tumor of lung) AND (M=secondhand smoke OR M=passive smoking OR M=environmental 
tobacco smoke OR M=indirect smoking OR R=secondhand smoke OR R=passive smoking OR 
R=environmental tobacco smoke OR R=indirect smoking)  
China Biology Medical 
literature database (in 
Chinese)
(“lung cancer”[title] OR “lung adenocarcinoma”[title] OR “squamous cell lung carcinoma”[title] OR 
“malignant tumor of lung”[title] OR “lung cancer”[abstract] OR “lung adenocarcinoma”[abstract] OR 
“squamous cell lung carcinoma”[abstract] OR “malignant tumor of lung”[abstract]) AND (“secondhand 
smoke”[title] OR “passive smoking”[title] OR “environmental tobacco smoke”[title] OR “indirect 
smoking”[title] OR “secondhand smoke”[abstract] OR “passive smoking”[abstract] OR “environmental 
tobacco smoke”[abstract] OR “indirect smoking”[abstract])




Matched factors in study design
Adjusted confounders in data analysis
TH Lam 1987 Women Extracted Age, place of residence No
LC Koo 1987 Women Calculated†† Age, district of residence, housing 
type
Age, number of live births, schooling, years since exposure to cigarette 
smoke ceased in the home or workplace
Q Liu 1993 Women Calculated‡ Age, residential district, date of 
diagnosis or hospital admission
Education, occupation, living area
X Sun 1995† Women Extracted Not provided Age, education
S Zheng 1997† Women + Men Extracted Age, sex No
L Zhong 1999 Women Calculated‡‡ Age Age, income, intake of vitamin C, respondent status, smokiness of the 
kitchen during cooking, family history of lung cancer, and potentially  
high-risk occupations
L Wang 2000 Women + Men Extracted Age, sex, prefecture Sex
CH Lee 2000 Women Calculated§ Age Residential area, education, occupation, tuberculosis, cooking fuels and 
fume extractor
YC Ko 2000 Women Calculated Age No
E Liu 2001† Women Extracted Age Age, monthly income
YM Chan 2003 Women + Men Calculated§§ Age, sex Place of birth, educational status, a family history of lung cancer, history of 
tuberculosis, exposure to insecticide/pesticide, diet
M Li 2005† Women Calculated Age No
IT Yu 2006 Women Calculated Age No
J Fang 2006† Women Extracted Age No
C Galeone 2008 Women + Men Extracted Age, sex, area of residence Income, family history of lung and other cancers, occupational exposure to 
recognized lung carcinogens
LA Tse 2009 Men Extracted Age Age, place of birth, alcohol drinking, residential radon exposure, past history 
of lung diseases, any cancer in first-degree relatives, intakes of meat, 
exposure to known or suspected lung carcinogens, and adoption of dust 
control
T Jiang 2010† Women + Men Extracted Age, sex BMI, lived nearby (≤3 km) factories, moved into newly renovated homes, 
Family cancer history, history of lung disease, regular consumption of soy 
foods, eating fruit and vegetable, regular participating in physical exercise, 
mental and psychological, heavy work pressure factors, sleep quality
M Huang 2011† Women + Men Calculated¶ Age, sex Age, sex, ethnic, education, BMI
L Mu 2013 Women + Men Extracted Age, sex Age, education level, annual personal income
YW Ren 2013 Women Extracted Age No
YL Lo 2013 Women + Men Calculated¶¶ Age, sex, ethnic Age, years of education. For women additionally adjusted for family 
history of lung cancer, tuberculosis, fume extractor in kitchen, hormone 
replacement therapy
X Xue 2013 Women Calculated Age No
Z Yin 2014 Women Extracted Age Age
S Li 2014 Women Calculated Age No
J Pan 2014† Women Extracted Age, cancer history, residence 
years
No
L Yang 2015 Women + Men Extracted Age, sex Age, sex, BMI, educational experience, study center, and pre-existing 
tuberculosis, pre-existing emphysema, occupational exposure to metallic 
toxicant, housing ventilation, biomass burning, cured meat consumption, 
vegetables/fruits consumption
Z Liu 2015† Women + Men Extracted Age, sex Age, sex, education, BMI
X Fang 2016 Women Calculated Age No
L Han 2017 Women + Men Calculated Age, sex No
J Pan 2018 Women Calculated Age No
R Qu 2019 Women Calculated Age No
†, study published in Chinese language; ††, overall OR was calculated by pooling OR for “1–19”, “20–34”, “35+” exposure years in this article; ‡, overall OR was calculated 
by pooling OR for “1–19”, “≥20” exposed cigarettes smoked per day by husband in this article; ‡‡, overall OR was calculated by pooling OR for childhood only, adulthood 
only and both ages in this article; §, overall OR was calculated by pooling OR for different groups of smoker-year in this article; §§, overall OR was calculated by pooling 
OR for men and women in this article; ¶, overall OR was calculated by pooling OR for light and heavy exposure in this article; ¶¶, overall OR was calculated by pooling OR 
for household and workplace exposure in men and household and workplace exposure in women in this article. OR, odds ratio.
Table S3 Quality assessment of the eligible studies for systematic review and meta-analysis
Author Year Selection (4 stars) Comparability (2 stars) Exposure (3 stars)
TH Lam 1987 **** * **
LC Koo 1987 *** * *
Q Liu 1993 *** * **
X Sun† 1995 *** * *
S Zheng† 1997 **** * *
L Zhong 1999 **** ** **
L Wang 2000 **** * **
CH Lee 2000 *** ** **
YC Ko 2000 *** * **
E Liu† 2001 **** * **
M Chan-Yeung 2003 *** ** *
M Li† 2005 *** * *
IT Yu 2006 *** * *
J Fang† 2006 *** * *
C Galeone 2008 *** ** *
LA Tse 2009 **** ** *
T Jiang† 2010 *** ** **
M Huang† 2011 *** * *
L Mu 2013 *** * **
YW Ren 2013 *** * *
YL Lo 2013 *** ** **
X Xue 2013 *** * **
Z Yin 2014 *** * *
S Li 2014 *** * **
J Pan† 2014 **** * *
L Yang 2015 **** ** *
Z Liu† 2015 *** * **
X Fang 2016 *** * *
L Han 2017 *** * *
J Pan 2018 *** * **
R Qu 2019 *** * *
Performed using the Newcastle-Ottawa Scale (NOS), one star (*) was awarded if the rating item was met. †, study published in Chinese 
language.
Table S4 Definition of never smoker and passive smoking across the included studies
Author Year Definition of never smoker Definition of passive smoking
TH Lam 1987 One who had never smoked as much as one cigarette a day or equivalent for 
the duration of one year
A woman was considered exposed to her husband’s tobacco smoke if she had lived 
together with her smoking husband in the same household for at least one year 
continuously
LC Koo 1987 Never-smoked subjects were defined as those who had smoked less than 20 
cigarettes in the past
NA
Q Liu 1993 NA NA
X Sun 1995 NA NA
S Zheng 1997 NA NA
L Zhong 1999 NA NA
L Wang 2000 Never smoked cigarettes or pipes regularly for 6 months or longer NA
CH Lee 2000 People who did not smoke as much as one cigarette per day for one year, or 
365 cigarettes over their lifetime were considered lifetime non-smokers
Passive smoker was identified as a patient whose family members had smoked in her 
“presence,” as some Chinese smokers do not smoke at home in the presence of their family
YC Ko 2000 A nonsmoker was defined as a woman who had never smoked one cigarette 
during her lifetime
Subjects who lived or worked with a smoker during their childhood and adulthood, such as 
a parent, husband, cohabitant, or coworker, were considered passive smokers
E Liu 2001 NA NA
Moira Chan-Yeung 2003 NA Life-long nonsmoker exposed to anyone who smoked at home or workplace regularly for at 
least 2 years
M Li 2005 NA NA
IT Yu 2006 NA Ever lived or worked with a smoker for at least 1 year and was regularly exposed to tobacco 
smoke
J Fang 2006 Consumed less than 100 cigarettes in total or smoked less than 6 months NA
C Galeone 2008 NA NA
LA Tse 2009 A non-smoker was defined as one who had never smoked as many as  
20 packs of cigarettes or 12 ounces (340.2 g) of tobacco in his lifetime or  
1 cigarette a day or 1 cigar a week for 1 year
Ever lived or worked with a smoker for at least 1 year and was regularly exposed to tobacco 
smoke
T Jiang 2010 NA NA
M Huang 2011 NA Exposed to the anyone’s tobacco smoke for more than 15 minutes per day
L Mu 2013 NA NA
YW Ren 2013 Those who had consumed as much as one cigarette per day for 1 month in 
their lifetime were defined as smokers, otherwise they were considered as 
nonsmokers
Passive smokers if they were exposed to the smoke from more than one cigarette per day 
for at least 1 year
YL Lo 2013 A never smoker was defined as someone who had never smoked or not 
smoked 1 cigarette a day or 1cigarette a week for 6 months at any period 
during his/her lifetime
Subject’s regular exposure to tobacco smoke by living or working with a smoker.
X Xue 2013 An individual was defined as a smoker if she had consumed a total of 100 
cigarettes in her lifetime; otherwise, she was considered as a non-smoker
NA
Z Yin 2014 Individual with a total of 100 cigarettes in his lifetime was defined as a smoker; 
otherwise, he was considered as a non-smoker
NA
S Li 2014 An individual was defined as a smoker if she had consumed a total of 100 
cigarettes in her lifetime; otherwise, she was considered as a non-smoker
NA
J Pan 2014 Someone who had never smoked or not smoked 1 cigarette a day or smoked 
less than 6 months
NA
L Yang 2015 Those participants who had smoked <100 cigarettes in their lifetime were 
defined as never smokers
NA
Z Liu 2015 Consumed less than 100 cigarettes in total Nonsmoker exposed to tobacco smoke for at least 1 day per week (more than 15 minutes 
per day)
X Fang 2016 In their lifetime, subjects who had smoked less than 100 cigarettes were 
defined as non-smokers
Individuals who had been exposed to the secondhand smoke of one cigarette every day for 
at least one year were defined as passive smokers
L Han 2017 Who had never smoked or had smoked fewer than 100 cigarettes during their 
lifetime
NA
J Pan 2018 Persons consuming 1 or more cigarettes per day for more than 1 month or if 
the cumulative amount reaches this level during a short period of
Time were excluded from the study
Subjects exposed to 1 or more cigarettes per day for a period of more than 1 year.
R Qu 2019 Individuals having a total of 100 cigarettes in their entire life were defined as 
smokers, otherwise as nonsmokers
Passive smokers were subjects who were exposed to more than one cigarette smoke per 








Aim of the study
Methods
Study design (n:n matched) case-control study, Prospective/ Retrospective cohort study
Study population (male/female/both)
Study period
Setting (population-based /hospital-based study)
Definition of non-smoker 
Region
Cases (or outcome in case of cohort study)
Source of lung cancer cases
Diagnostic criteria for lung cancer
In- and exclusion criteria of lung cancer





In- and exclusion criteria of controls
Passive smoking
Definition of PS





Follow-up (years) (in case of cohort study)
No. of loss to follow up (in case of cohort study)
Age (mean ± SD/range)
Table for overall No. of cases No. of controls
No. of PS
No. of non-PS
Table for female No. of cases No. of controls
No. of PS
No. of non-PS
Table for male No. of cases No. of controls
No. of PS
No. of non-PS
Crude OR/RR and 95% CI
Adjusted OR/RR and 95% CI
Adjusted confounding factors 
Conclusion
Figure S1 Data extraction form. Note: more tables can be added if needed. CI, confidence interval; OR, odds ratio; PS, passive smoking; 
RR, relative risk.
Figure S2 Sensitivity analysis for the association between passive smoking and lung cancer risk among never smokers in China. 
Figure S3 Funnel plot of publication for the association between 
passive smoking and lung cancer risk among never smokers in 
China. 
Figure S4 Funnel plot of possible publication bias in population-
based studies. Data are for the association between passive smoking 
and lung cancer risk among never smokers in China. 
Figure S5 Funnel plot of possible publication bias in hospital-based studies. Data are for the association between passive smoking and lung 
cancer risk among never smokers in China. 
Figure S6 Forest plot of the random effects meta-analysis in population-based studies. Data are for the association between passive smoking 
and lung cancer risk among never smokers for women and men in China. CI, confidence interval; OR, odds ratio. 
Figure S7 Forest plot of the random effects meta-analysis in hospital-based studies. Data are for the association between passive smoking 
and lung cancer risk among never smokers for women and men in China. CI, confidence interval; OR, odds ratio. 
Figure S8 Forest plot of random effects meta-analysis for the association between passive smoking and lung cancer among female never 
smokers by exposure source in China. CI, confidence interval; OR, odds ratio. 
Figure S9 Forest plot of random effects meta-analysis for the association between passive smoking and lung cancer among never smokers by 
histological type in China. CI, confidence interval; OR, odds ratio.
